A New Staging System for Coronary Artery Disease

When diagnosed with conditions such as cancer and hypertension, standard practice is for patients to learn their prognosis and receive a treatment plan. This is based on a staging system, which looks at how far the disease has progressed. Notably missing from this list of conditions is coronary artery disease (CAD), the number one cause of death in the U.S. In this episode, returning guest Dr. James Min, CEO and founder of Cleerly, the company creating a new standard of precision heart care, discusses a new paper published in the “Journal of Cardiovascular Computed Tomography” proposing a four-stage system for the disease burden of atherosclerotic plaque, the direct cause of CAD, and what it means for future disease treatment.

James K. Min, MD is Founder and CEO of Cleerly, the company creating a new standard of precision heart care. Dr. Min is a former Professor of Radiology and Medicine at Weill Cornell Medical College and the Director of the Dalio Institute of Cardiovascular Imaging (ICI) at NewYork-Presbyterian. He is a board-certified cardiologist with a clinical focus on cardiovascular disease prevention and cardiovascular imaging.  Min received his BA from the University of Chicago, and his medical degree from Temple University Medical School. He completed his internship, residency and cardiovascular medicine fellowship at the University of Chicago Hospitals.